STAAR Surgical Company Common Stock (STAA)

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, h…

Sector

Health Care

Industry

Ophthalmic Goods

Employees

921

Website

www.staar.com

Fundamentals

1-day range

$24.81$26.25

Market cap

$1.15B

P/E (trailing)

327.25

P/E (forward)

26.34

EPS (trailing)

$0.08

Dividend yield

—

Beta

1.23

Avg. volume

872.4K

Forecasts

10 analyst ratings

STAAR Surgical Company Common Stock Competitors

Chosen by industry and closest market cap.

• STAA

  STAAR Surgical Company Common Stock

  $22.1

  ▼ 1.30%
  Market cap $1.15BP/E 327.25
  $15.59$35.87
• EYE

  National Vision Holdings Inc. Common Stock

  $17.37

  ▼ 2.80%
  Market cap $1.80BP/E 34.05
  $14.75$30.02
• LUCY

  Innovative Eyewear Inc. Common Stock

  $0.97

  ▲ 3.08%
  Market cap $6.19MP/E —
  $0.65$2.24
• LUCYW

  Innovative Eyewear Inc. Series A Warrants 8/16/27

  $0.035

  ▼ 16.86%
  Market cap $556.8KP/E —
  $0.0251$0.181
• WRBY

  Warby Parker Inc. Class A Common Stock

  $25

  ▼ 1.07%
  Market cap $3.31BP/E 401.34
  $14.96$31
• BLCO

  Bausch + Lomb Corporation Common Shares

  $17.15

  ▲ 0.12%
  Market cap $5.84BP/E —
  $13.77$18.92
• COO

  The Cooper Companies Inc. Common Stock

  $71.15

  ▲ 0.27%
  Market cap $14.30BP/E 63.74
  $58.89$89.83

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28
  benzinga · 8/17/2026
• UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19
  Benzinga · 8/13/2026
• Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37
  Benzinga · 8/13/2026
• STAAR Surgical Company (STAA) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/12/2026
• Staar Surgical Q2 EPS $0.16 Beats $0.15 Estimate, Sales $93.535M Beat $90.589M Estimate
  Benzinga · 8/12/2026
• STAAR Surgical Appoints Warren Foust As President And CEO, Effective August 4; Names Deborah Andrews EVP And CFO
  Benzinga · 8/4/2026
• Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target
  Benzinga · 8/4/2026

• Warren Foust · July 31, 2026 · Option Exercise

  20.8K
• Warren Foust · July 31, 2026 · Tax Withholding

  10.6K @ $24.36
• Deborah J. Andrews · July 31, 2026 · Option Exercise

  20.8K
• Deborah J. Andrews · July 31, 2026 · Tax Withholding

  10.6K @ $24.36
• Deborah J. Andrews · June 25, 2026 · Option Exercise

  14.0K
• Deborah J. Andrews · June 25, 2026 · Tax Withholding

  6.5K @ $31.21
• Wang Christopher Min Fang · June 18, 2026 · Grant

  11.1K
• Lilian Yansheng Zhou · June 18, 2026 · Grant

  5.6K
• Lilian Yansheng Zhou · June 18, 2026 · Grant

  3.1K
• Wei Jiang · June 18, 2026 · Grant

  6.2K
• Wei Jiang · June 18, 2026 · Option Exercise

  10.7K
• Arthur C. Butcher · June 18, 2026 · Grant

  3.7K
• Arthur C. Butcher · June 18, 2026 · Grant

  4.5K
• Arthur C. Butcher · June 18, 2026 · Option Exercise

  5.3K
• LeBuhn Richard T. · June 18, 2026 · Grant

  11.1K

Institutional Ownership

March 31, 2026

Total shares held

52.29M

Total value held

$968.72M

Institutional holders

181